Cancer incidence in adolescents and young adults in the United States, 1992-1997

Journal of Adolescent Health

Volumn 32, Issue 6, 2003, Pages 405-415

  Wu, Xiao Cheng ^a   Chen, Vivien W ^a   Steele, Brooke ^b   Roffers, Steven ^c   Klotz, Judith B ^d   Correa, Catherine N ^a   Carozza, Susan E ^e  

^a LA Stt Univ Health Sciences Center ^*  (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^c EMORY UNIVERSITY   (United States)

^d NEW JERSEY DEPARTMENT OF HEALTH AND SENIOR SERVICES   (United States)

^e TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Adolescent; Cancer incidence patterns; Cancer registry; Epidemiology; Gender differences; Young adult

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; AGE; ARTICLE; BONE CANCER; BRAIN CANCER; CANCER INCIDENCE; CANCER REGISTRY; FEMALE; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; LEUKEMIA; MALE; MELANOMA; NONHODGKIN LYMPHOMA; OVARY CANCER; OVARY CARCINOMA; POPULATION RESEARCH; PRIORITY JOURNAL; SEX DIFFERENCE; TESTIS CANCER; THYROID CANCER; UNITED STATES;

EID: 0037986206     PISSN: 1054139X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1054-139X(03)00057-0     Document Type: Article

References (70)

1. Lewis I.J. Cancer in adolescence. Br Med Bull. 52:1996;887-897.
2. Bleyer W.A., Tejeda H., Murphy S.B., et al. National cancer clinical trials Children have equal access; adolescents do not . J Adol Health. 21:1997;366-373.
3. Reaman G.H., Bonfiglio J., Krailo M., et al. Cancer in adolescents and young adults. Cancer. 71:1993;3206-3209.
4. Tejeda H.A., Green S.B., Trimble E.L., et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst. 88:1996;812-816.
5. Rivera G.K., Pui C.H., Santana V.M., et al. Progress in the treatment of adolescents with acute lymphoblastic leukemia. Cancer. 71:1993;3400-3405.
6. Hayes-Jordan A.A., Spunt S.L., Poquette C.A., et al. Nonrhabdomyosarcoma soft tissue sarcoma in children Is age at diagnosis an important variable? J Pediatr Surg. 35:2000;948-953.
7. Chen WV, Howe HL, Wu XC. et al (eds). Cancer in North America, 1993–1997. Volume One: Incidence. Springfield, IL: North American Association of Central Cancer Registries, April 2000.
8. Ries L.A.G., Smith M.A., Gurney J.G., et al. Cancer Incidence and Survival among Children and Adolescents United States SEER Program 1975–1995. NIH Pub. No. 99-4649 . 1999;National Cancer Institute, SEER Program, Bethesda, MD.
9. Kramarova E., Stiller C.A. The international classification of childhood cancer. Int J Cancer. 68:1996;759-765.
10. Percy C, Van Holten V, Muir C. International Classification of Diseases for Oncology. 2nd edition. Geneva, Switzerland: World Health Organization, 1990.
11. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER Cancer Statistics Review, 1973–1998. 2001;National Cancer Institute, Bethesda, MD.
12. Parkin DM, Shanmugaratnam K, Sobin L, et al. Histologic groups for comparative studies. IARC Technical Report No. 31. Lyon, 1998.
13. IMS [Information Management Service, Inc.]. SEER*Stat 4.2. Internet address: http//seer.cancer.gov/seerstat/index.html [accessed July 20, 2002].
14. Miller R.W., Myers M.H. Age-distribution of epithelial and non-epithelial cancers. Lancet. 2:1983;1250.
15. Fritschi L., Coates M., McCredie M. Incidence of cancer among New South Wales adolescents Which classification scheme describes adolescent cancers better? Int J Cancer. 60:1995;355-360.
16. Medeiros L.J., Greiner T.C. Hodgkin’s disease. Cancer. 75:(Suppl 1):1995;357-369.
17. Jarrett A.F., Armstrong A.A., Alexander E. Epidemiology of EBV and Hodgkin’s lymphoma. Ann Oncol. 7:(Suppl 4):1996;5-10.
18. Vineis P., Miligi L., Crosignani P., et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Commun Health. 54:2000;907-911.
19. Sleckman B.G., Mauch P.M., Ambinder R.F., et al. Epstein-Barr virus in Hodgkin lymphoma Correlation of risk factors and disease characteristics with molecular evidence of viral infection . Cancer Epidemiol Biomarkers Prev. 7:1998;1117-1121.
20. Westergaard T., Melbye M., Pedersen J.B., et al. Birth order, sibship size and risk of Hodgkin’s disease in children and young adults A population-based study of 31 million person-years . Int J Cancer. 72:1997;977-981.
21. Stiller C.A. What causes Hodgkin’s disease in children? Eur J Cancer. 34:1998;523-528.
22. Alexander F.E., Ricketts T.J., McKinney P.A., et al. Community lifestyle characteristics and lymphoid malignancies in young people in the UK. Eur J Cancer. 27:1991;1486-1490.
23. Gutensohn N., Cole P. Childhood social environment and Hodgkin’s disease. N Engl J Med. 304:1981;135-140.
24. Jarrett R.F., Gallagher A., Jones D.B., et al. Detection of Epstein-Barr virus genomes in Hodgkin’s disease Relation to age . J Clin Pathol. 44:1991;844-848.
25. Weiss L.M., Strickler J.G., Warnke R.A., et al. Epstein-Barr viral DNA in tissues of Hodgkin’s disease. Am J Pathol. 129:1987;86-91.
26. Muller N.E. Hodgkin’s disease. Schottenfeld D., Franmeni J. Jr. Cancer Epidemiology and Prevention. 1996;893-919 Oxford, New York.
27. Dorfman R.F. Malignant lymphoma. Introduction. Monogr Pathol. 29:1995;1.
28. Copelan E.A., McGuire E.A. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 85:1995;1151-1168.
29. McNally R.J., Rowland D., Roman E., et al. Age and sex distributions of hematological malignancies in the UK. Hematol Oncol. 15:1997;173-189.
30. Howe H.L., Wingo P.A., Thun M.J., et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst. 93:2001;824-842.
31. Hernandez J.A., Land K.J., McKenna R.W. Leukemias, myeloma, and other lymphoreticular neoplasms. Cancer. 75:(Suppl 1):1995;381-394.
32. Chow W.-H., Linet M., Liff J., et al. Cancers in children. Schottenfeld D., Franmeni J. Jr. Cancer Epidemiology and Prevention. 1996;1331-1369 Oxford, New York.
33. Sandler D.P., Ross J.A. Epidemiology of acute leukemia in children and adults. Semin Oncol. 24:1997;3-16.
34. Robison L., Ross J. Epidemiology of leukemias and lymphomas in childhood. Chessells J., Hann I. Bailliere’s Clinics Paediatrics. 1995;639-657 WB Saunders, London.
35. Smith M., Rubinstein L., Ungerleider R. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins Estimating the risks . Med Pediatr Oncol. 23:1994;86-98.
36. Hunger S., Sklar J., Link M. Acute lymphoblastic leukemia occurring as second malignant neoplasm in childhood Report of three cases and review of the literature . J Clin Oncol. 10:1992;156-163.
37. Casagrande J.T., Louie E.W., Pike M.C., et al. “Incessant ovulation” and ovarian cancer. Lancet. 2:1979;170-173.
38. Fathalla M.F. Incessant ovulation—A factor in ovarian neoplasia? Lancet. 2:1971;163.
39. Stadel B.V. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol. 123:1975;772-774.
40. Coble Y.D., Kohler P.O., Cargille C.M., et al. Production rates and metabolic clearance rates of human follicle stimulating hormone in pre-menopausal and post-menopausal women. J Clin Invest. 48:1969;359-363.
41. Baker H.W., Burger H.G., de Kretser D.M., et al. Changes in the pituitary-testicular system with age. Clin Endocrinol. 5:1976;349-372.
42. Walker A.H., Ross R.K., Haile R.W., et al. Hormonal factors and risk of ovarian germ cell cancer in young women. Br J Cancer. 57:1988;418-422.
43. Rodriguez E., Houldsworth J., Reuter V.E., et al. Molecular cytogenetic analysis of i(12p)-negative human male germ-cell tumors. Genes Chromosomes Cancer. 8:1993;230-236.
44. Bosl G.J., Ilson D.H., Rodriguez E., et al. Clinical relevance of the i(12p) marker chromosome in germ-cell tumors. J Natl Cancer Inst. 86:1994;349-355.
45. Mostert M.C., Verkerk A.J., van de Pol M., et al. Identification of the critical region of 12p over-representation in testicular germ-cell tumors of adolescents and adults. Oncogene. 16:1998;2617-2627.
46. Van Echten J., Oosterhuis J.W., Looijenga L.H., et al. No recurrent structural abnormalities apart from i(12p) in primary germ-cell tumors of the adult testis. Genes Chromosomes Cancer. 14:1995;133-144.
47. Zahm S.H., Fraumeni J.F. Jr. The epidemiology of soft tissue sarcoma. Semin Oncol. 24:1997;504-514.
48. Renwick N., Halaby T., Weverling G.J., et al. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi’s sarcoma. AIDS. 12:1998;2481-2488.
49. Engels E.A. Human immunodeficiency virus infection, aging, and cancer. J Clin Epidemiol. 54:2001;S29-S34.
50. Diagnosis and reporting of HIV and AIDS in states with HIV/AIDS surveillance—United States, 1994–2000. MMWR Morb Mortal Wkly Rep. 51:2002;595-598.
51. Wang X.P., Zhang Y.J., Deng J.H., et al. Transcriptional regulation of Kaposi’s sarcoma-associated herpesvirus-encoded oncogene viral interferon regulatory factor by a novel transcriptional silencer, Tis. J Biol Chem. 277:2002;12023-12031.
52. Sola P., Bedin R., Casoni F., et al. New insights into the viral theory of amyotrophic lateral sclerosis Study on the possible role of Kaposi’s sarcoma-associated virus/human herpesvirus 8 . Eur Neurol. 47:2002;108-112.
53. Dilnur P., Katano H., Wang Z.H., et al. Classic type of Kaposi’s sarcoma and human herpesvirus 8 infection in Xinjiang, China. Pathol Int. 51:2001;845-852.
54. Liu S., Semenciw R., Waters C., et al. Time trends and sex patterns in Hodgkin’s disease incidence in Canada, 1970–1995. Can J Public Health. 91:2000;188-192.
55. Armstrong B.K. Cutaneous malignant melanoma. Schottenfeld D., Fraumeni J.F. Jr. Cancer Epidemiology and Prevention. 1996;1282-1312 Oxford University Press, New York.
56. Elder D.E. Skin cancer Melanoma and other specific nonmelanoma skin cancers . Cancer. 75:(Suppl 1):1995;245-256.
57. Smith M.A., Fine J.A., Barnhill R.L., et al. Hormonal and reproductive influences and risk of melanoma in women. Int J Epidemiol. 27:1998;751-757.
58. Neil S.M., Eves P., Richardson B., et al. Oestrogenic steroids and melanoma cell interaction with adjacent skin cells influence invasion of melanoma cells in vitro. Pigment Cell Res. 13:(Suppl 8):2000;68-72.
59. Miller J.G., Gee J., Price A., et al. Investigation of oestrogen receptors, sex steroids and soluble adhesion molecules in the progression of malignant melanoma. Melanoma Res. 7:1997;197-208.
60. Stoica A., Hoffman M., Marta L., et al. Estradiol and progesterone receptors in human cutaneous melanoma. Neoplasms. 38:1991;137-145.
61. Boice J.D., Land C.E. Ionizing radiation. Schottenfeld D., Fraumeni T. Cancer Epidemiology and Prevention. 1982;231-253 WB Saunders, Philadelphia.
62. Correa P., Chen V.W. Endocrine gland cancer. Cancer. 75:(suppl 2):1995;338-352.
63. Ron E., Kleinerman R.A., Boice J.D. Jr, et al. A population-based case-control study of thyroid cancer. J Natl Cancer Inst. 79:1987;1-12.
64. Mettlin C., Croghan I., Natarajan N., et al. The association of age and familial risk in a case-control study of breast cancer. Am J Epidemiol. 131:1990;973-983.
65. Hulka B.S., Stark A.T. Breast cancer Cause and prevention . Lancet. 346:1995;883-887.
66. Kelsey J.L., Gammon M.D., John E.M. Reproductive factors and breast cancer. Epidemiol Rev. 15:1993;36-47.
67. Schiffman M.H., Kiviat N.B., Burk R.D., et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol. 33:1995;545-550.
68. Ylitalo N., Sorensen P., Josefsson A.M., et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ A nested case-control study . Lancet. 355:2000;2194-2198.
69. Ho G.Y., Bierman R., Beardsley L., et al. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 338:1998;423-428.
70. Sherlaw-Johnson C., Gallivan S., Jenkins D., et al. Cytological screening and management of abnormalities in prevention of cervical cancer An overview with stochastic modelling . J Clin Pathol. 47:1994;430-435.